FAF1 Antibody

What is FAF1 and what is its molecular profile?

FAF1 (Fas-associated factor 1) is a protein that functions as a member of the Fas death-inducing signal complex. It has a calculated molecular weight of 650 amino acids and 74 kDa, which corresponds to its observed molecular weight in experimental conditions . FAF1 is encoded by the FAF1 gene (Gene ID: 11124) and has been assigned the UniProt ID Q9UNN5 . The protein is most abundantly expressed in testis, followed by skeletal muscle and heart, with lower expression in prostate, thymus, ovary, small intestine, and colon, but is notably absent in peripheral blood leukocytes .

What are the primary applications for FAF1 antibodies in research?

FAF1 antibodies are typically used in several standard laboratory applications:

The antibody has been tested and shown reactivity with human, mouse, and rat samples, making it versatile for comparative studies across these species .

How should FAF1 antibodies be stored and handled for optimal performance?

FAF1 antibodies should be stored at -20°C for long-term storage, where they remain stable for up to one year . For shorter periods (up to three months), storage at 4°C is acceptable . The typical storage buffer consists of PBS with 0.02% sodium azide and 50% glycerol at pH 7.3 . It is important to avoid repeated freeze-thaw cycles as these can compromise antibody integrity and performance . For antibodies in liquid form, aliquoting is unnecessary for -20°C storage according to some manufacturers, though this may vary by product .

What is the functional significance of FAF1 in cellular processes?

The N-terminal region (amino acids 1-201) of FAF1, which includes the upstream ubiquitin homology domain, can bind with the death domain of Fas . This interaction mediates programmed cell death (apoptosis) in various organ systems, particularly in the immune and nervous systems . Recent research has also revealed that FAF1 plays a crucial role in inflammatory responses to bacterial infection through reactive oxygen species (ROS) production . FAF1 has been shown to interact with diverse molecules and modulate a variety of biological processes beyond apoptosis .

How does FAF1 regulate innate immune responses during bacterial infection?

Research has revealed that FAF1 functions as a positive regulator that enhances the activity of the phagocytic NADPH oxidase complex . This interaction results in:

• Increased production of reactive oxygen species (ROS)

• Activation of NF-κB signaling pathways

• Enhanced inflammatory responses

• Improved antibacterial activity, particularly during Listeria monocytogenes infection

Studies using FAF1 knockdown models have demonstrated that reduced FAF1 expression leads to decreased cytokine production (including IL-6 and IL-12) and diminished secretion of chemokines such as RANTES and MCP-1 . This indicates that FAF1 is essential for mounting effective inflammatory responses against bacterial pathogens.

What is the molecular mechanism by which FAF1 interacts with the NADPH oxidase complex?

FAF1 has been shown to transiently interact with the p67phox-p47phox-p40phox complex during the early stages of bacterial infection in macrophages . Specifically:

• The region comprising amino acids 330-489 of FAF1 is responsible for interaction with the TPR domain of p67phox

• This interaction stabilizes p67phox and increases the activity of phagocytic NADPH oxidase

• The enhanced NADPH oxidase activity leads to increased ROS production

• The ROS subsequently activates NF-κB signaling and inflammatory responses

This molecular interaction explains the mechanistic basis for FAF1's role in promoting antibacterial responses during intracellular microbial infection .

What are the implications of FAF1 expression levels in pathological conditions?

High expression of FAF1 has been associated with poor prognosis in certain conditions, as suggested by ongoing research . In experimental settings, FAF1 knockout or knockdown models (FAF1 gt/gt mice) exhibited:

• Reduced serum cytokine levels

• Decreased inflammatory gene expression

• Increased bacterial burden during L. monocytogenes infection

• Compromised ROS production and inflammatory responses in primary macrophages

These findings indicate that while appropriate FAF1 expression is essential for normal immune function, its dysregulation may contribute to pathological states, suggesting potential therapeutic implications for modulating FAF1 activity in disease contexts.

What are the optimal protocols for using FAF1 antibody in Western blot analyses?

For Western blot analysis of FAF1, the following methodological considerations are important:

• Sample preparation: Cell lysates (such as THP-1 or HEK-293) are commonly used for detecting FAF1

• Antibody dilution: The recommended dilution range is typically 1:500-1:2000 for Western blot applications , or 1-2 μg/mL as suggested by some manufacturers

• Expected band size: The observed molecular weight of FAF1 is approximately 74 kDa

• Optimization: It is recommended that the antibody be titrated in each testing system to obtain optimal results, as the optimal dilution may be sample-dependent

When validating a new antibody, it is advisable to include appropriate positive and negative controls to ensure specificity, particularly when working with different species or cell types.

How should immunohistochemistry (IHC) be optimized for FAF1 detection in tissue samples?

For optimal FAF1 detection using IHC, follow these methodological guidelines:

• Sample preparation: Formalin-fixed paraffin-embedded (FFPE) sections should be deparaffinized and rehydrated

• Antigen retrieval: This critical step should be performed to expose epitopes that may have been masked during fixation

• Endogenous peroxidase inhibition: Treat with hydrogen peroxide following antigen retrieval

• Antibody incubation: Incubate with primary FAF1 antibody (starting concentration of 2.5 μg/mL) overnight, followed by appropriate secondary antibody incubation

• Detection system: Use appropriate detection systems such as N-Histofine Simple Stain MAX-PO MULTI or similar reagents

• Scoring: FAF1 protein expression can be graded according to staining intensity and percentage of positive cells

For rat spleen tissue, FAF1 antibody at 2.5 μg/mL has been validated for immunohistochemical analysis .

What controls and validation experiments should be included when using FAF1 antibody in new experimental systems?

When implementing FAF1 antibody in a new experimental system, include these validation steps:

• Positive controls: Use tissues or cell lines with known FAF1 expression (such as testis, skeletal muscle, or HEK-293 cells)

• Negative controls: Include samples where primary antibody is omitted or use tissues with minimal FAF1 expression (such as peripheral blood leukocytes)

• Knockdown/knockout validation: When possible, include FAF1 knockdown or knockout samples to confirm specificity

• Cross-reactivity testing: If working across species, validate the antibody's reactivity in the specific species of interest

• Multiple detection methods: Confirm findings using at least two independent detection methods (e.g., WB and IF)

• Molecular weight verification: Confirm that detected bands match the expected molecular weight of FAF1 (74 kDa)

These validation steps ensure reliable and reproducible results across different experimental conditions.

How can inconsistent or weak FAF1 antibody signals in Western blots be resolved?

When encountering weak or inconsistent FAF1 signals in Western blot, consider these troubleshooting approaches:

• Antibody dilution optimization: Test a range of dilutions, starting with manufacturer recommendations (1:500-1:2000)

• Sample preparation optimization: Ensure sufficient protein loading and consider using protease inhibitors during lysis

• Blocking optimization: Test different blocking reagents to reduce background while maintaining specific signal

• Incubation conditions: Adjust primary antibody incubation time (overnight at 4°C vs. shorter periods at room temperature)

• Detection system sensitivity: Consider enhanced chemiluminescence (ECL) systems with higher sensitivity

• Protein degradation: FAF1 may be subject to degradation; ensure fresh samples and proper storage

Remember that FAF1 expression varies across tissues, with highest expression in testis and lower levels in other tissues , which may affect signal intensity in different experimental systems.

What factors should be considered when interpreting FAF1 immunostaining patterns in different cell types?

When analyzing FAF1 immunostaining patterns:

• Subcellular localization: Consider the expected subcellular distribution of FAF1 based on its known functions in apoptosis and immune regulation

• Cell type-specific expression: Remember that FAF1 expression varies significantly across different cell and tissue types

• Activation state: Consider that inflammatory stimuli may alter FAF1 expression and localization, particularly in immune cells

• Background vs. specific staining: Distinguished based on controls and known expression patterns

• Co-staining validation: When possible, co-stain with markers of specific cellular compartments or interacting partners (such as p67phox)

• Quantification methods: Use appropriate methods to quantify staining intensity and distribution when making comparative analyses

This contextual interpretation is essential for understanding the biological significance of FAF1 localization and expression patterns.

How can FAF1 antibodies be validated for studying protein-protein interactions, particularly with the NADPH oxidase complex?

For studying FAF1 interactions with the NADPH oxidase complex:

• Co-immunoprecipitation: Use anti-FAF1 antibody for immunoprecipitation followed by Western blot detection of potential interaction partners (p67phox, p47phox, p40phox)

• Proximity ligation assays: Consider this technique to visualize and quantify interactions between FAF1 and NADPH oxidase components

• Domain mapping: Use constructs expressing specific domains of FAF1 (particularly the region comprising amino acids 330-489) to validate domain-specific interactions

• Temporal dynamics: Assess the transient nature of the interactions at different time points following stimulation

• Functional validation: Complement interaction studies with functional assays measuring ROS production and inflammatory responses

Research has specifically identified the interaction between the 330-489 amino acid region of FAF1 and the TPR domain of p67phox as critical for NADPH oxidase activity regulation .

How can FAF1 antibodies be used to investigate the role of FAF1 in inflammatory and immune responses?

FAF1 antibodies can be employed in several research strategies to elucidate its role in inflammation:

• Temporal expression analysis: Monitor FAF1 expression levels at different time points following inflammatory stimuli or bacterial infection

• Co-localization studies: Use immunofluorescence to assess the co-localization of FAF1 with NADPH oxidase components during immune cell activation

• Signaling pathway analysis: Combine FAF1 detection with phospho-specific antibodies against NF-κB pathway components to establish signaling relationships

• Knockdown/knockout complementation: Use FAF1 antibodies to confirm restoration of expression in rescue experiments

• Clinical correlation studies: Analyze FAF1 expression in patient samples in relation to inflammatory biomarkers and disease parameters

These approaches can help elucidate the mechanistic role of FAF1 in regulating inflammatory responses and host defense mechanisms against bacterial infections .

What are promising research directions for understanding FAF1's role in apoptosis versus inflammation?

Future research directions might explore:

• Context-dependent functions: Investigate how FAF1 differentially regulates apoptosis versus inflammatory pathways in different cellular contexts

• Post-translational modifications: Study how modifications of FAF1 may switch its function between different cellular processes

• Structural biology approaches: Determine the three-dimensional structure of FAF1, particularly in complex with its interaction partners

• Tissue-specific regulation: Explore why FAF1 is highly expressed in certain tissues (testis, skeletal muscle, heart) and how this relates to its function

• Disease models: Investigate FAF1's role in animal models of inflammatory diseases, cancer, and neurodegenerative disorders

These research directions could reveal novel therapeutic targets by understanding how FAF1 integrates apoptotic and inflammatory signals in health and disease.